Stock UTHR UNITED THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Governance United Therapeutics Corporation

Equities

UTHR

US91307C1027

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 11:04:19 2024-09-10 EDT 		5-day change 1st Jan Change
344.50 USD -1.21% Intraday chart for United Therapeutics Corporation -2.38% +56.44%
09-05 Transcript : United Therapeutics Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-05-2024 08:00 AM
09-04 United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing MT

Executive Committee: United Therapeutics Corporation

Manager
Positions heldSince
Martine Rothblatt

Martine Rothblatt

69 year

Chief Executive Officer 1996-06-25
Founder 1996-06-25
Paul Mahon

Paul Mahon

60 year

General Counsel 2000-12-31
Corporate Secretary 2000-12-31
James Edgemond

James Edgemond

56 year

Director of Finance/CFO 2015-03-12
Treasurer 2012-12-31
Michael Benkowitz

Michael Benkowitz

52 year

Chief Operating Officer 2016-06-25
President 2016-06-25
Dewey Steadman

Dewey Steadman

Investor Relations Contact 2018-12-31

Composition of the Board of Directors: United Therapeutics Corporation

Director
CommitteesSince
Martine Rothblatt

Martine Rothblatt

69 year

Chairman 1996-06-25
Judy Olian

Judy Olian

72 year

Audit Committee
Compensation Committee
Governance Committee 2018-09-12
Nominating Committee 2014-04-30
Compensation Committee Chair
Louis Sullivan

Louis Sullivan

90 year

Compensation Committee 2013-03-06
Governance Committee 2011-11-13
Nominating Committee 2011-11-13
Compensation Committee Chair 2011-11-13
Nilda Mesa

Nilda Mesa

64 year

Compensation Committee 2018-10-30
Governance Committee 2018-10-30
Nominating Committee 2018-10-30
Richard Giltner

Richard Giltner

60 year

Governance Committee 2009-04-28
Nominating Committee 2009-04-28
Audit Committee Chair 2009-04-28
Christopher Causey

Christopher Causey

61 year

Audit Committee 2002-12-31
Governance Committee Chair 2012-08-08
Nominating Committee Chair 2012-08-08
Christopher Patusky

Christopher Patusky

60 year

Governance Committee 2002-10-23
Nominating Committee 2002-10-23
Compensation Committee Chair 2002-10-23
Linda Maxwell

Linda Maxwell

50 year

Audit Committee 2021-03-28
Compensation Committee Chair 2021-03-28
Tommy Thompson

Tommy Thompson

81 year

Audit Committee
Raymond Dwek

Raymond Dwek

82 year

Compensation Committee 2001-12-31
Raymond Kurzweil

Raymond Kurzweil

76 year

Executive Committee
Jan Malcolm

Jan Malcolm

67 year

Director/Board Member 2024-06-25
Independent Dir/Board Member 2024-06-25

Latest Appointments: United Therapeutics Corporation

United Therapeutics Corporation Announces Board Changes CI
United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors as an Independent Director CI
United Therapeutics Corporation Appoints Nilda Mesa as an Independent Director CI
United Therapeutics Corporation Announces Executive Leadership Changes, Effective June 26, 2016 CI
United Therapeutics Corporation Appoints Dean Judy D. Olian as Member of the Board CI
United Therapeutics Corporation Announces Executive Promotions, Effective January 1, 2015 CI
Katherine J. Klein Joins the United Therapeutics Corporation Board of Directors CI
More news

Former Officers and Directors: United Therapeutics Corporation

Insider
Positions held
SinceUntil
Katherine Klein
Katherine Klein
Director/Board Member 2014-11-10 2024-06-25
Independent Dir/Board Member 2014-11-10 2024-06-25
Kiernan T. DeAngelis
Kiernan T. DeAngelis
Chief Tech/Sci/R&D Officer 2013-01-31 2017-04-30
Tracy Newbold
Tracy Newbold
Chief Operating Officer 2010-12-31 2016-12-31
Roger Jeffs
Roger Jeffs
Director/Board Member 2001-03-31 2016-06-25
Chief Executive Officer 2014-12-31 2016-06-25
Chief Operating Officer 2001-03-31 2013-12-31
Chief Tech/Sci/R&D Officer 1998-08-31 2001-03-31
President 2001-03-31 2016-06-25
David Zaccardelli
David Zaccardelli
Chief Operating Officer 2003-12-31 2016-06-25
Corporate Officer/Principal 2007-12-31 2014-12-31
L. Smith
L. Smith
Corporate Officer/Principal 2014-11-30 2016-05-31
Scott Moomaw
Scott Moomaw
Sales & Marketing 2010-12-31 2016-04-30
Alexander Sapir
Alexander Sapir
Sales & Marketing 2005-12-31 2016-04-30
John Maxim Ferrari
John Maxim Ferrari
Comptroller/Controller/Auditor 2001-04-30 -
Director of Finance/CFO 2001-04-30 2015-03-12
Treasurer 2001-04-30 2015-03-12
Martin Auster
Martin Auster
Corporate Officer/Principal 2009-02-28 2014-04-30
Eugene Jeffrey Sullivan
Eugene Jeffrey Sullivan
Chief Tech/Sci/R&D Officer 2006-12-31 2011-12-31
Robert G. L. Shorr
Robert G. L. Shorr
Chief Tech/Sci/R&D Officer 2004-12-31 2004-12-31
Stuart Rich
Stuart Rich
Chief Tech/Sci/R&D Officer 2003-09-30 2004-11-30
Robert Paul Gray
Robert Paul Gray
Director/Board Member 2002-12-31 -
Independent Dir/Board Member 2002-12-31 -
Wayne I. Roe
Wayne I. Roe
Corporate Officer/Principal 1999-10-31 2000-10-31
Bill Cook
Bill Cook
Corporate Officer/Principal - -
David Green
David Green
Director/Board Member - -
Tessio Rebello
Tessio Rebello
Chief Tech/Sci/R&D Officer 2009-07-15 2009-07-15
Corporate Officer/Principal 2009-05-21 2009-07-15
President - 2009-05-21
Carl Sterritt
Carl Sterritt
Corporate Officer/Principal - -
Peter L. Ginsberg
Peter L. Ginsberg
Corporate Officer/Principal - -
Matthew M. Seavey
Matthew M. Seavey
Corporate Officer/Principal - -
Henry Hicks
Henry Hicks
Director/Board Member - -
Ricardo Balda
Ricardo Balda
Director/Board Member - -
Fred T. Hadeed
Fred T. Hadeed
Corporate Officer/Principal - -
Robert F. Roscigno
Robert F. Roscigno
Director/Board Member - -
Corporate Officer/Principal - -
Jinky Ang Rosselli
Jinky Ang Rosselli
Corporate Officer/Principal - -
David G. Walsh
David G. Walsh
Corporate Officer/Principal - -

Age distribution of managers

Parity Men Women

Male 14
Female 2

Of which Executive Committee

Male 5
Female 0

Of which Directors

Male 10
Female 2
ESG Refinitiv
B+

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Company Profile

Logo United Therapeutics Corporation
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Employees
1,168
Sector
Biotechnology & Medical Research
Calendar
2024-10-29 - Q3 2024 Earnings Release (Projected)
More about the company

Departures of Key Persons

Roger Jeffs
-
Roger Jeffs

Chief Executive Officer

2014-12-31 2016-06-25

  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. Company United Therapeutics Corporation
  5. Governance
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition